TABLE 1.

Baseline patient characteristics (n = 8676).

Age, years	59.8 ± 8.9
Male, n (%)	5977 (68.9)
On anti‐hypertensive drug, n (%)	2443 (28.2)
On oral hypoglycemic agent, n (%)	863 (9.9)
On insulin, n (%)	103 (1.2)
On lipid‐lowering agent, n (%)	3013 (34.7)
Current smoker, n (%)	4249 (49.0)
Ex‐smoker, n (%)	342 (3.9)
BMI (kg/m2)	24.1 ± 3.1
HbA1c, %	5.7 (5.4–6.0)
Fasting serum glucose, mg/dL	101 (94–110)
Total cholesterol, mg/dL	190 (161–219)
Triglyceride, mg/dL	97 (69–137)
HDL cholesterol, mg/dL	51 (44–60)
Non‐HDL cholesterol, mg/dL	136 (108–165)
DLDL, mg/dL	118 (92–144)
FLDL, mg/dL	114 (87–141)
MLDL, mg/dL	115 (89–141)
EMLDL, mg/dL	115 (89–141)
SLDL, mg/dL	116 (90–143)
CACS	2.7 (0.0–75.6)

Note: SI conversion factor: To convert low‐density lipoprotein cholesterol levels to millimoles per liter, multiply by 0.0259; and to convert TGs to millimoles per liter, multiply by 0.0113. Values are presented as the mean ± SD, median (interquartile range), or a number (percentage), unless otherwise indicated.

Abbreviations: BMI, body mass index; CACS, coronary artery calcium score; DLDL, directly measured LDL‐cholesterol; EMLDL, LDL‐cholesterol estimated using extended Martin/Hopkins equation; FLDL, LDL‐cholesterol estimated using Friedewald equation; HbA1c, glycated hemoglobin; HDL, high‐density lipoprotein; MLDL, LDL‐cholesterol estimated using Martin/Hopkins equation; SLDL, LD,‐cholesterol estimated using Sampson equation; VLDL‐C, very‐low‐density lipoprotein cholesterol.